The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory CommitteeElı́as Campo, Andrew D. Zelenetz, Ari Melnick et al.|Blood|2022Cited by 1.5k
Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysisMassimo Federico, Bertrand Coiffier, María Dolores Caballero Barrigón et al.|The Lancet Haematology|2018Cited by 116
Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic–pharmacodynamic analysis from the IELSG no. 20 trialMarkus Joerger, Andrés J.M. Ferreri, A. D. R. Huitema et al.|British Journal of Cancer|2010Cited by 85
Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAndrés J.M. Ferreri, M. Dreyling, Gerald Illerhaus et al.|Annals of Oncology|2024Cited by 46
Dosing algorithm to target a predefined AUC in patients with primary central nervous system lymphoma receiving high dose methotrexateMarkus Joerger, Alwin D. R. Huitema, Andrés J.M. Ferreri et al.|British Journal of Clinical Pharmacology|2011Cited by 36